Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25]
- 20ul selling size
- RabMAb
- Recombinant
- What is this?
3
(13 Reviews)
|
(99 Publications)
Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117) is a rabbit monoclonal antibody detecting RIP3 in Western Blot, ELISA, Dot Blot. Suitable for Mouse.
- Biophysical QC for unrivalled batch-batch consistency
- Over 70 publications
View Alternative Names
Rip3, Ripk3, Receptor-interacting serine/threonine-protein kinase 3, RIP-like protein kinase 3, Receptor-interacting protein 3, RIP-3, mRIP3
- WB
Supplier Data
Western blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (AB195117)
Blocking/Dilution buffer : 5% NFDM/TBST.
Lysates were provided by Xiaodong Wang, National Institute of Biological Sciences, Beijing
All lanes:
Western blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117) at 1/2000 dilution
Lane 1:
Untreated TSE (WT) whole cell lysate at 10 µg
Lane 2:
TSE (WT) whole cell lysate treated with 20 ng/ml TNF alpha,100 nM Smac mimetic, and 20 µM z-VAD for 12 h and then harvested at 10 µg
Lane 3:
Untreated TSE (KO RIP3) whole cell lysate at 10 µg
Lane 4:
TSE (KO RIP3) whole cell lysate treated with 20 ng/ml TNF alpha,100 nM Smac mimetic, and 20 µM z-VAD for 12 h and then harvested at 10 µg
Lane 5:
Untreated TSE (KO MLKL) whole cell lysate at 10 µg
Lane 6:
TSE (KO MLKL) whole cell lysate treated with 20 ng/ml TNF alpha,100 nM Smac mimetic, and 20 µM z-VAD for 12 h and then harvested at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/1000 dilution
Predicted band size: 57 kDa
Observed band size: 53 kDa
false
Exposure time: 30s
- WB
Supplier Data
Western blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (AB195117)
Blocking and diluting buffer : 5% NFDM/TBST.
ab181602 was used as a loading control at 1/1000000 dilution.
We recommend involving downstream protein p-MLKL as a control to validate the stimulation of p-RIP3.
Lanes 1 - 4:
Western blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117) at 1/1000 dilution
Lanes 5 - 8:
Western blot - Anti-MLKL (phospho S345) antibody [EPR9515(2)] (<a href='/en-us/products/primary-antibodies/mlkl-phospho-s345-antibody-epr95152-ab196436'>ab196436</a>) at 1/1000 dilution
Lanes 1, 3, 5 and 7:
Untreated L-929 (mouse connective tissue fibroblast cell line) whole cell lysate at 20 µg
Lanes 2 and 6:
L-929 (mouse connective tissue fibroblast cell line) treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 μM z-VAD for 8 hours whole cell lysate at 20 µg
Lanes 4 and 8:
L-929 (mouse connective tissue fibroblast cell line) treated with 20 ng/ml TNF-a, 100 nM Smac mimetic and 20 μM z-VAD for 6 hours whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 57 kDa,54 kDa
Observed band size: 53 kDa
false
Exposure time: 180s
- WB
Unknown
Western blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (AB195117)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117) at 1/10000 dilution
Lane 1:
Untreated L-929 (Mouse connective tissue fibroblast cell line) whole cell lysate at 10 µg
Lane 2:
L-929 (Mouse connective tissue fibroblast cell line) whole cell lysate treated with phosphatase at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 57 kDa
Observed band size: 53 kDa
false
Exposure time: 3min
- ELISA
Supplier Data
ELISA - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (AB195117)
Serially diluted ab195117 was bound to immobilized phospho or non-phospho (control) peptide demonstrating minimal cross-reactivity to the non-phosphorylated residue. Antigen - RIP3 (phospho S232) phospho peptide;RIP3 non-phospho peptide at 250 ng/ml. Primary antibody concentration range : 0 - 500 ng/ml. Secondary antibody - Alkaline Phosphatase-conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) at 1 : 2500.
- Dot
Supplier Data
Dot Blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (AB195117)
Primary antibody : ab195117 at 1 : 1000 dilution (1.6μg/ml), secondary antibody : Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated (ab97051) at 1 : 1000 dilution, Blocking and dilution buffer : 5% NFDM/TBST, Lane 1 : RIP3 (phospho S232) phospho peptide, Lane 2 : RIP3 Non-phospho peptide, Exposure time : 3 minutes.
We observed weak binding to the non-phospho peptide at very high concentrations.
- WB
CiteAb
Western blot - Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (AB195117)
RIP3 (phospho S232) western blot using anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] ab195117. Publication image and figure legend from Siegmund, D., Ehrenschwender, M., et al., 2018, Cell Death Dis, PubMed 30206205.
ab195117 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab195117 please see the product overview.
TNFR2-induced upregulation of A20 and TRAF1 is not an epiphenomenon of TNFR2-triggered necroptosis.a Wild-type, RIPK3-, and MLKL-knockout macrophages were stimulated as indicated with human TNF (100 ng/ml), TNC-sc(mu)TNF80 (200 ng/ml), and ZVAD (20 μM). Cell viability was quantified after 36 h using MTT. Data points of five independent experiments were shown with mean ± SEM (***p < 0.001). b, c RIPK3- (b) and MLKL- (c) knockout macrophages along with wild-type macrophages were treated overnight with the indicated combinations of 200 ng/ml TNC-sc(mu)TNF80, 100 ng/ml human TNF, 20 μM ZVAD, and necrostatin-1 (45 μM). Total cell lysates were prepared and analyzed by western blot. d Wild-type and TNFR2-knockout macrophages were stimulated for 7 h with human TNF (100 ng/ml) or TNC-sc(mu)TNF80 (200 ng/ml) in the presence and absence of ZVAD (20 μM), and total cell lysates were analyzed by western blot for RIPK1 phosphorylation. e The various macrophage types were stimulated for 36 h with the indicated mixtures of TNC-sc(mu)TNF80 (200 ng/ml), ZVAD (20 μM), and necrostatin-1 (45 μM). IL-1β in the supernatants was determined by ELISA assay. Shown are the mean ± SEM of five or six independent experiments. ***p < 0.001
false
Related conjugates and formulations (1)
-
Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] - BSA and Azide free
Reactivity data
Product details
What is this antibody validated in?
Anti-RIP3 (phospho S232) antibody [EPR9516(N)-25] (ab195117) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), ELISA, Dot Blot in Mouse samples.
What is the molecular weight of RIP3?
Anti-RIP3 (phospho S232) [EPR9516(N)-25] (ab195117) specifically detects a band for RIP3 (UniProt: Q9QZL0) at a molecular weight of 53kDa.
Trusted by the scientific community
Anti-RIP3 (phospho S232) [EPR9516(N)-25] (ab195117) was first used in a scientific publication in 2016 and has been cited over 70 times in peer-reviewed journals.
Reviewed by scientists
Anti-RIP3 (phospho S232) [EPR9516(N)-25] (ab195117) has over 10 independent reviews from customers.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Other related products
We have a range of other formats of antibody clone [EPR9516(N)-25] also available for your convenience: ab195117, Carrier free - ab240336
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
RIP3 facilitates the execution of necroptosis a form of programmed cell death distinct from apoptosis. It becomes activated upon binding with RIP1 forming a necrosome complex that is essential for this pathway. This complex promotes phosphorylation events that subsequently lead to membrane rupture and cell death. Apart from its role in necroptosis RIP3 also engages in metabolic regulation processes linking energy status and cell death under conditions of stress.
Pathways
RIP3 is a principal component of the necroptotic pathway interacting closely with RIP1 to trigger cell death in conditions where caspase activation is inhibited. Alternatively it integrates into metabolic pathways participating in sensing and responding to changes in cellular energy states. The interplay between RIP3 and RIP1 within these pathways illustrates their shared involvement in maintaining cellular homeostasis and triggering cell death when necessary.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (99)
Recent publications for all applications. Explore the full list and refine your search
Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 50:970-985 PubMed41015557
2025
Applications
Unspecified application
Species
Unspecified reactive species
Viruses 17: PubMed41012634
2025
Applications
Unspecified application
Species
Unspecified reactive species
Research (Washington, D.C.) 8:0823 PubMed40822127
2025
Applications
Unspecified application
Species
Unspecified reactive species
JCI insight 10: PubMed40401524
2025
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in pharmacology 16:1546950 PubMed40351427
2025
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 31: PubMed40211716
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:1890 PubMed39987261
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cell communication and signaling : CCS 22:566 PubMed39587603
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed39519224
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of biological sciences 20:4713-4730 PubMed39309425
2024
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com